Form CORRESP - Correspondence:
SEC Accession No. 0001731122-25-001001
Filing Date
2025-07-21
Accepted
2025-07-21 15:39:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 6090
  Complete submission text file 0001731122-25-001001.txt   7116
Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: CORRESP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)